| 0.3814 0.016 (4.32%) | 10-24 14:50 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.54 | 1-year : | 0.62 |
| Resists | First : | 0.46 | Second : | 0.53 |
| Pivot price | 0.41  |
|||
| Supports | First : | 0.35 | Second : | 0.29 |
| MAs | MA(5) : | 0.38 |
MA(20) : | 0.43 |
| MA(100) : | 6.41 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 11.2 |
D(3) : | 14.2 |
| RSI | RSI(14): 31.9 |
|||
| 52-week | High : | 41.49 | Low : | 0.35 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PHH ] has closed above bottom band by 30.1%. Bollinger Bands are 98.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 63 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.38 - 0.38 | 0.38 - 0.38 |
| Low: | 0.35 - 0.35 | 0.35 - 0.36 |
| Close: | 0.36 - 0.37 | 0.37 - 0.37 |
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Fri, 24 Oct 2025
Park Ha Biological Technology Co., Ltd. Changes Nasdaq Ticker Symbol to BYAH - TipRanks
Fri, 24 Oct 2025
Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH - FinancialContent
Thu, 23 Oct 2025
Why LendingClub Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Wed, 08 Oct 2025
Park Ha Biological Technology Co., Ltd. Announces Dual-Class Share Structure - TipRanks
Sat, 06 Sep 2025
Park Ha Biological Technology Faces Nasdaq Compliance Challenges - The Globe and Mail
Thu, 10 Jul 2025
Pharma Boom: Park Ha’s Stocks After Latest Innovation - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 0 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 1.069e+007 (%) |
| Held by Institutions | 63.6 (%) |
| Shares Short | 762 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.899e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 591 % |
| Return on Equity (ttm) | -298.2 % |
| Qtrly Rev. Growth | 2.77e+006 % |
| Gross Profit (p.s.) | 0.08 |
| Sales Per Share | 0.09 |
| EBITDA (p.s.) | 0.03 |
| Qtrly Earnings Growth | -0.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 4.27 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 359310 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|